Premium
Erythroleukaemia in a Melphalan‐Treated Patient with Primary Macroglobulinaemia
Author(s) -
Petersen Helena Søndergaard
Publication year - 1973
Publication title -
scandinavian journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 84
eISSN - 1600-0609
pISSN - 0036-553X
DOI - 10.1111/j.1600-0609.1973.tb00031.x
Subject(s) - melphalan , medicine , chemotherapy
Within the last two years, the development of acute leukaemia after long‐continued treatment with alkylating cytostatic agents has repeatedly been reported. A watch is therefore kept for the possible leukaemogenic action of these drugs. In view of this, it will be of interest to report a case in which erythroleukaemia developed in an 81‐year‐old man with macroglobulinaemia who had been treated with melphalan for 3 1/2 years.